Next Article in Journal
Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages
Previous Article in Journal
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
Previous Article in Special Issue
Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications
Open AccessReview

Emerging Vaccine Technologies

The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA 19104, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Vaccines 2015, 3(2), 429-447; https://doi.org/10.3390/vaccines3020429
Received: 24 December 2014 / Revised: 5 May 2015 / Accepted: 18 May 2015 / Published: 26 May 2015
(This article belongs to the Special Issue Vaccine Vector)
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. View Full-Text
Keywords: vaccine; reverse vaccinology; structural vaccinology; epitope-scaffold; immunoprophylaxis vaccine; reverse vaccinology; structural vaccinology; epitope-scaffold; immunoprophylaxis
MDPI and ACS Style

Loomis, R.J.; Johnson, P.R. Emerging Vaccine Technologies. Vaccines 2015, 3, 429-447.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop